Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6455-6474
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6455
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6455
Table 3 Summary of the multivariable regression analyses for clinical outcomes in the included moderate to severe Crohn’s disease patients
Outcome type | Disease remission | CD-related surgery | CD-related complications | Utility, quality of life | ||||||||||||||||
Regression analysis method | Logistic regression analysis | Logistic regression analysis | Logistic regression analysis | Beta-binomial regression analysis | ||||||||||||||||
Independent variables | Sample size | OR | 95%CI | P value | Sample size | OR | 95%CI | P value | Sample size | OR | 95%CI | P value | Sample size | Coefficient | 95%CI | P value | ||||
Lower | Upper | Lower | Upper | Lower | Upper | Lower | Upper | |||||||||||||
IMT vs CMT | 389 | 4.060 | 1.643 | 10.753 | 0.003a | 389 | 0.658 | 0.349 | 1.249 | 0.196 | 389 | 0.527 | 0.323 | 0.858 | 0.010a | 389 | 0.822 | 0.218 | 1.426 | 0.008a |
Demographics | ||||||||||||||||||||
Male gender | 389 | 1.111 | 0.675 | 1.844 | 0.681 | 389 | -0.008 | -0.622 | 0.607 | 0.980 | ||||||||||
Age in yr | 389 | 0.951 | 0.918 | 0.986 | 0.005 | 389 | 1.027 | 1.002 | 1.052 | 0.035a | 389 | 0.990 | 0.968 | 1.011 | 0.351 | 389 | -0.016 | -0.041 | 0.010 | 0.223 |
BMI | ||||||||||||||||||||
< 18.5 | 389 | 1.936 | 0.682 | 6.535 | 0.244 | |||||||||||||||
18.5-23.9 | 389 | 0.826 | 0.292 | 2.755 | 0.733 | |||||||||||||||
Residence area | ||||||||||||||||||||
Urban city | 389 | 0.521 | 0.246 | 1.035 | 0.073 | |||||||||||||||
Insurance plan | ||||||||||||||||||||
Farmar | 389 | 0.384 | 0.098 | 1.634 | 0.178 | |||||||||||||||
Other plans | 389 | 2.578 | 1.034 | 6.247 | 0.038a | |||||||||||||||
Disease site at diagnosis | ||||||||||||||||||||
Terminal ileum | 389 | 1.350 | 0.612 | 3.042 | 0.460 | 389 | 1.246 | 0.732 | 2.104 | 0.414 | 389 | -0.227 | -0.847 | 0.392 | 0.472 | |||||
Colon | 389 | 0.812 | 0.385 | 1.762 | 0.590 | 389 | 1.581 | 0.756 | 3.247 | 0.216 | ||||||||||
History of CD-related complications | ||||||||||||||||||||
Intestinal fistula | 389 | 0.307 | 0.098 | 0.976 | 0.042a | |||||||||||||||
Intestinal obstruction | 389 | 0.831 | 0.322 | 2.293 | 0.709 | |||||||||||||||
Extraintestinal abscess | 389 | 5.766 | 1.277 | 25.741 | 0.020a | |||||||||||||||
Anal fistula | 389 | 0.747 | 0.350 | 1.509 | 0.431 | 389 | 0.142 | -0.546 | 0.829 | 0.687 | ||||||||||
Joint pain | 389 | 0.318 | 0.059 | 1.866 | 0.187 | |||||||||||||||
History of CD-related surgery | 389 | 0.158 | 0.056 | 0.407 | 0.000 | 389 | 0.488 | 0.282 | 0.824 | 0.009b | 389 | -0.304 | -0.908 | 0.299 | 0.323 | |||||
Comorbidities | ||||||||||||||||||||
Gallbladder disease | 389 | 3.812 | 1.343 | 11.494 | 0.013a | |||||||||||||||
Kidney disease | 389 | 5.015 | 0.826 | 31.142 | 0.070 |
- Citation: Shi JH, Luo L, Chen XL, Pan YP, Zhang Z, Fang H, Chen Y, Chen WD, Cao Q. Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China. World J Gastroenterol 2020; 26(41): 6455-6474
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6455.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6455